| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |